We advised Hayfin Capital Management on its hybrid capital investment in LXO Group

Davis Polk advised Hayfin Capital Management in connection with its hybrid capital investment in LXO Group.

As well as refinancing existing indebtedness of LXO Group, the transaction also involved the acquisition by the group of the marketing authorization for Barhemsys (amisulpride) in the United States from Eagle Pharmaceuticals, further bolstering LXO Group’s portfolio in hospital-based therapeutics. The partnership with Hayfin, alongside LXO Group’s majority shareholders, Stanley Capital Partners, significantly strengthens the business and provides the required resources to execute its long-term growth strategy and value creation plan.

LXO Group is a leading integration platform for mature medicines that are essential for millions of patients and healthcare professionals. As a lifecycle management specialist with a focus on cardiovascular and central nervous system products, its portfolio consists of category-leading branded products addressing chronic diseases with a history of highly sustainable revenues and robust organic growth.

Hayfin Capital Management is a leading alternative asset management firm with approximately €35 billion in assets under management. Hayfin focuses on delivering attractive risk-adjusted returns for its investors across its private debt, liquid credit and private equity solutions businesses. Hayfin has a diverse international team of over 200 experienced industry professionals with offices globally, including headquarters in London and offices in Chicago, Dubai, Frankfurt, Luxembourg, Madrid, Milan, Munich, New York, Paris, Stockholm, San Diego and Tokyo.

Stanley Capital Partners is an investment firm focused on building and scaling businesses and platforms in sustainable growth sectors. The firm partners with management teams, in majority and minority transactions, to transform and grow companies to unlock their potential.

The Davis Polk finance team included partners Nick Benham and Luke McDougall, counsel Phil Anscombe and associate Megha Mehrotra. The private equity team included counsel William Tong and associates Felix Jiang and Jack Spain. Partner Dominic Foulkes and associate Patrick O’Donovan provided tax advice. All members of the Davis Polk team are based in the London office.

Copy link to share post